Addex Therapeutics Ltd (ADXN) — Financial Flexibility Index
Addex Therapeutics Ltd (ADXN) has a Financial Flexibility Index of -0.38x as of March 2026. Free cash flow of $-608.40K (operating CF $-608.40K minus capex $0.00) represents 0% of total liabilities ($1.60 Million). Check Addex Therapeutics Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Addex Therapeutics Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Addex Therapeutics Ltd across 20 annual periods. See Addex Therapeutics Ltd (ADXN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Addex Therapeutics Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Addex Therapeutics Ltd. For the full company profile including market capitalisation, see ADXN stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.30x | $-2.08 Million | $-2.08 Million | $1.60 Million | ▲ +75.8% |
| 2024 | -5.37x | $-5.37 Million | $-5.37 Million | $1.00 Million | ▼ -135.0% |
| 2023 | -2.28x | $-7.99 Million | $-7.99 Million | $3.50 Million | ▲ +53.2% |
| 2022 | -4.88x | $-16.44 Million | $-16.44 Million | $3.37 Million | ▼ -86.5% |
| 2021 | -2.62x | $-14.67 Million | $-14.71 Million | $5.61 Million | ▼ -20.2% |
| 2020 | -2.18x | $-12.12 Million | $-12.18 Million | $5.57 Million | ▼ -72.7% |
| 2019 | -1.26x | $-9.45 Million | $-9.48 Million | $7.50 Million | ▼ -312.7% |
| 2018 | 0.59x | $1.76 Million | $1.75 Million | $2.97 Million | ▲ +147.7% |
| 2017 | -1.24x | $-2.13 Million | $-2.13 Million | $1.72 Million | ▲ +32.3% |
| 2016 | -1.83x | $-2.68 Million | $-2.69 Million | $1.46 Million | ▲ +14.2% |
| 2015 | -2.14x | $-2.62 Million | $-2.63 Million | $1.23 Million | ▼ -96.2% |
| 2014 | -1.09x | $-1.80 Million | $-1.80 Million | $1.65 Million | ▲ +80.3% |
| 2013 | -5.53x | $-15.78 Million | $-15.78 Million | $2.85 Million | ▼ -3.4% |
| 2012 | -5.35x | $-29.12 Million | $-29.45 Million | $5.44 Million | ▼ -98.5% |
| 2011 | -2.69x | $-26.35 Million | $-26.55 Million | $9.78 Million | ▲ +13.9% |
| 2010 | -3.13x | $-30.89 Million | $-31.34 Million | $9.87 Million | ▲ +2.4% |
| 2009 | -3.20x | $-35.17 Million | $-39.38 Million | $10.97 Million | ▼ -250.9% |
| 2008 | -0.91x | $-12.18 Million | $-17.79 Million | $13.34 Million | ▲ +72.0% |
| 2007 | -3.27x | $-30.28 Million | $-33.00 Million | $9.27 Million | ▲ +30.7% |
| 2006 | -4.71x | $-19.20 Million | $-19.56 Million | $4.07 Million | — |